Skip to main content
SpringerLink
Log in

Visfatin/pre-B-cell colony-enhancing factor: A protein with various suggested functions

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Pre-B-cell colony-enhancing factor (PBEF) was recently found in high levels in visceral fat, and was therefore renamed visfatin. This new adipocytokine exerts insulin-mimetic effects in mice and in cultured cells by binding to and activating the insulin receptor. Despite some recent studies on this topic, the proposed role of visfatin in metabolism remains largely unknown. Initially, PBEF/visfatin was discovered as a cytokine for the differentiation of B-cells. Pre-B-cell colony-enhancing factor was also shown to inhibit apoptosis of neutrophils in sepsis and was discussed as a novel biomarker for acute lung injury (ALI). Although PBEF is missing a signal sequence, its secretion and function as a molecule involved in the regulation of inflammatory processes was reported in several studies. Investigations of PBEF/visfatin in gestational membranes suggest a function in the physiologic and pathologic pathways leading to labor. Furthermore, it was found upregulated in colorectal cancer and was brought into connection with the regulation of the cell cycle. Intra-cellular, PBEF/visfatin acts as a cytosolic enzyme involved in nicotinamide adenine dinucleotide (NAD) synthesis. This activity was shown to be important for vascular smooth muscle cell (SMC) maturation, indicating a possible involvement in vascular pathology. The important physiologic role of PBEF/visfatin is also underlined by its evolutionary highly conserved gene in different species. This review summarizes the current knowledge of the various functions of PBEF/visfatin towards involvements in pathophysiology of several diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kershaw EE, Flier SF. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89: 2548–56.

    Article  PubMed  CAS  Google Scholar 

  2. Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14: 1431–7.

    PubMed Central  PubMed  CAS  Google Scholar 

  3. Ognjanovic S, Bao S, Yamamoto SY, Garibay-Tupas J, Samal B, Bryant-Greenwood GD. Genomic organization of the gene coding for human pre-B-cel colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001, 26: 107–17.

    Article  PubMed  CAS  Google Scholar 

  4. Kitani T, Okuno S, Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS 2003, 544: 74–8.

    Article  CAS  Google Scholar 

  5. Mc Glothlin JR, Gao L, Lavoie T, et al. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. Biochem Genet 2005, 43: 127–41.

    Article  PubMed  CAS  Google Scholar 

  6. Fujiki K, Shin DH, Nakao M, Yano T. Molecular cloning and expression analysis of the putative carp (Cyprinus carpio) pre-B cell enhancing factor. Fish Shellfish Immunol 2000, 10: 383–5.

    Article  PubMed  CAS  Google Scholar 

  7. Martin PR, Shea RJ, Mulks MH. Identification of a plasmidencoded gene from haemophilus ducreyi which confers NAD independence. J Bacteriol 2001, 183: 1168–74.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Muller WE, Perovic S, Wilkesman J, Kruse M, Muller IM, Batel R. Increased gene expression of a cytokine-related molecule and profilin after activation of Suberites domuncula cells with xenogeneic sponge molecule(s). DNA Cell Biol 1999, 18: 885–93.

    Article  PubMed  CAS  Google Scholar 

  9. Muller WE, Wiens M, Muller IM, Schroeder HC. The chemokine network in sponges: potential roles in morphogenesis, immunity and stem cell formation. Prog Mol Subcell Biol 2004, 34: 103–43.

    Article  PubMed  CAS  Google Scholar 

  10. Ye SQ, Simon BA, Maloney J P, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 2005, 171: 361–70.

    Article  PubMed  Google Scholar 

  11. Shin DH, Oganesyan N, Jancarik J, Yokota H, Kim R, Kim SH. Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum. J Biol Chem 2005, 18: 18326–35.

    Article  CAS  Google Scholar 

  12. Patrone L, Damore MA, Lee MB, Malone CS, Wall R. Genes expressed during the IFNγ-induced maturation of pre-B cells. Mol Immunol 2002, 38: 597–606.

    Article  PubMed  CAS  Google Scholar 

  13. Xu LG, Wu M, Hu J, Zhai Z, Shu HB. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J Leukoc Biol 2002, 72: 410–6.

    PubMed  CAS  Google Scholar 

  14. Turpaev K, Bouton C, Diet A, Glatigny A, Drapier JC. Analysis of differentially expressed genes in nitric oxide-exposed human monocytic cells. Free Radic Biol Med 2005, 38: 1392–400.

    Article  PubMed  CAS  Google Scholar 

  15. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004, 113: 1318–27.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  16. Ye SQ, Zhang LQ, Adyshev D, et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 2005, 70: 142–51.

    Article  PubMed  CAS  Google Scholar 

  17. Koczan D, Guthke R, Thiesen HJ, et al. Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol 2005, 15: 251–7.

    PubMed  CAS  Google Scholar 

  18. Otero M, Lago R, Gomez R, et al. Changes in fat-derived hormones plasma concentrations: adiponectin, leptin, resistin, and visfatin in rheumatoid arthritis subjects. Ann Rheum Dis 2006, 65: 1798–201.

    Article  CAS  Google Scholar 

  19. Nemeth E, Tashima LS, Yu Z, Bryant-Greenwood GD. Fetal membrane distension I. Differentially expressed genes regulated by acute distension in amniotic epithelial (WISH) cells. Am J Obstet Gynecol 2000, 182: 50–9.

    CAS  Google Scholar 

  20. Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002, 187: 1051–8.

    Article  PubMed  CAS  Google Scholar 

  21. Marvin KW, Keelan JA, Eykholt RL, Sato TA, Mitchell MD. Use of cDNA arrays to generate differential expression profiles for inflammatory genes in human gestational membranes delivered at term and preterm. Mol Hum Reprod 2002, 8: 399–408.

    Article  PubMed  CAS  Google Scholar 

  22. Ognjanovic S, Tashima LS, Bryant-Greenwood GD. The effects of pre-B-cell colony-enhancing factor on the human fetal membranes by microarray analysis. Am J Obstet Gynecol 2003, 189: 1187–95.

    Article  PubMed  CAS  Google Scholar 

  23. Ognjanovic S, Ku TL, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium. Am J Obstet Gynecol 2005, 193: 273–82.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  24. Krzyzanowska K, Krugluger W, Mittermayer F, et al. Incrased visfatin concentrations in women with gestational diabetes. Clin Sci (Lond) 2006, 110: 605–9.

    Article  CAS  Google Scholar 

  25. Hufton SE, Moerkerk PT, Brandwijk R, deBruine AP, Arends JW, Hoogenboom HR. A profile of differentially expressed genes in primary colorectal cancer using suppression substractive hybridization. FEBS 1999, 463: 77–82.

    Article  CAS  Google Scholar 

  26. van Beijnum JR, Moerkerk PT, Gerbers AJ, et al. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int J Cancer 2002, 101: 118–27.

    Article  PubMed  CAS  Google Scholar 

  27. Folgueira MA, Carraro DM, Brentani H, et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 2005, 11: 7434–43.

    Article  PubMed  CAS  Google Scholar 

  28. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol 2002, 32: 3225–34.

    Article  PubMed  CAS  Google Scholar 

  29. van der Veer E, Nong Z, O’Neil C, Urquhart B, Freeman D, Pickering JG. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005, 97: 25–34.

    Article  PubMed  CAS  Google Scholar 

  30. Archer SL. Pre-B-cell colony-enhancing factor regulates vascular smooth muscle maturation through a NAD+-dependent mechanism. Circ Res 2005, 97: 4–7.

    Article  PubMed  CAS  Google Scholar 

  31. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307: 426–30.

    Article  PubMed  CAS  Google Scholar 

  32. Curat CA, Wegner V, Senges C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49: 744–7.

    Article  PubMed  CAS  Google Scholar 

  33. Chen M P, Chung FM, Chang DM, et al. Elevated plasma levels of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006, 91: 295–9.

    Article  PubMed  CAS  Google Scholar 

  34. Berndt J, Klöting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expressions in humans. Diabetes 2005, 54: 2911–6.

    Article  PubMed  CAS  Google Scholar 

  35. Hammarstedt A, Pihlajamäki J, Sopasakis VR, et al. Visfatin is an adipokine but it is not regulated by thiazolidinediones. J Clin Endocrinol Metab 2006, 91: 1181–4.

    Article  PubMed  CAS  Google Scholar 

  36. Haider DG, Schindler K, Schaller G, Prager G, Wolzt M, Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 2006, 91: 1578–81.

    Article  PubMed  CAS  Google Scholar 

  37. Klöting N, Klöting I. Visfatin: Gene expression in isolated adipocytes and sequence analysis in obese WOKW rats compared with lean control rats. Biochem Biophys Res Commun 2005, 332: 1070–2.

    Article  PubMed  CAS  Google Scholar 

  38. Ando H, Yanagihara H, Hayashi Y, et al. Rhytmic mRNA expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 2005, 146: 5631–6.

    Article  PubMed  CAS  Google Scholar 

  39. Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 2005, 185: R1–R8.

    Article  PubMed  CAS  Google Scholar 

  40. Kralisch S, Klein J, Lossner U, et al. Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005, 289: 586–90.

    Article  CAS  Google Scholar 

  41. Choi KC, Ryu OH, Lee KW, et al. Effect of PPAR-α and -γ agonist on the expression of visfatin, adiponectin, and TNF-α in visceral fat of OLETF rats. Biochem Biophys Res Commun 2005, 336: 747–53.

    Article  PubMed  CAS  Google Scholar 

  42. Tang H, Cheung WM, Ip FC, Ip NY. Identification and charcterization of differentially expressed genes in denervated muscle. Mol Cell Neurosci 2000, 16: 127–40.

    Article  PubMed  CAS  Google Scholar 

  43. Hug C, Lodisch HF. Visfatin: A new adipocytokine. Science 2005, 307: 366–7.

    Article  PubMed  CAS  Google Scholar 

  44. Stephens JM, Vidal-Puig AJ. An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity. Curr Opin Lipidol 2006, 17: 128–31.

    Article  PubMed  CAS  Google Scholar 

  45. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115: 911–9.

    Article  PubMed  CAS  Google Scholar 

  46. Lin SJ, Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 2003, 15: 241–6.

    Article  PubMed  CAS  Google Scholar 

  47. Guarente L, Picard F. Calorie restriction — the SIR2 connection. Cell 2005, 120: 473–82.

    Article  PubMed  CAS  Google Scholar 

  48. Pilz S, Horejsi R, Möller R, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005, 90: 4792–6.

    Article  PubMed  CAS  Google Scholar 

  49. Libby P. Inflammation in atherosclerosis. Nature 2002, 420: 868–74.

    Article  PubMed  CAS  Google Scholar 

  50. Avogaro A, de Kreutzenberg SV. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta 2005, 360: 9–26.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Institute of Medical and Chemical Laboratory Diagnostics, Germany

    S. Pilz MD & H. Mangge

  2. Department of Pediatrics, Division of Pediatric Rheumatology/Immunology, Germany

    S. Pilz MD & H. Mangge

  3. Division of Endocrinology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

    B. Obermayer-Pietsch

  4. Synlab Center of Laboratory Diagnostics, Heidelberg, Germany

    W. März

Authors
  1. S. Pilz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Mangge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Obermayer-Pietsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. März
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Pilz MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pilz, S., Mangge, H., Obermayer-Pietsch, B. et al. Visfatin/pre-B-cell colony-enhancing factor: A protein with various suggested functions. J Endocrinol Invest 30, 138–144 (2007). https://doi.org/10.1007/BF03347412

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347412

Keywords

Search

Navigation